Patents by Inventor Kristina Kruglyak

Kristina Kruglyak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240136022
    Abstract: Provided herein are methods and kits for measuring fragment size distribution of DNA fragments from a sample of a subject, for the purposes of cancer or tumor detection, characterization, and/or management.
    Type: Application
    Filed: November 17, 2023
    Publication date: April 25, 2024
    Inventors: Kristina Kruglyak, Francesco Marass, Wai Yi Tsui
  • Publication number: 20230245724
    Abstract: Provided is a computer-implemented method, including inputting to a trained machine learning classifier genomic information of a non-training subject that includes features from a tumor sample, wherein the trained machine learning classifier trained on features of tumor samples obtained from training subjects and their a responsiveness to checkpoint inhibition treatment and the machine-learning classifier is trained to predict responsiveness to the treatment, and generating a checkpoint inhibition responsiveness classification predictive of the subject's responding to the checkpoint inhibition with the trained machine-learning classifier, and reporting the checkpoint inhibition responsiveness classification using a graphical user interface. Also provided are a computer system for performing the method and a machine learning classifier trained by the method.
    Type: Application
    Filed: December 3, 2018
    Publication date: August 3, 2023
    Applicant: ILLUMINA, INC.
    Inventors: Shile Zhang, Mengchi Wang, Aaron Wise, Han Kang, Vitor Ferreira Onuchic, Kristina Kruglyak
  • Publication number: 20200176083
    Abstract: Provided is a computer-implemented method, including inputting to a trained machine learning classifier genomic information of a non-training subject that includes features from a tumor sample, wherein the trained machine learning classifier trained on features of tumor samples obtained from training subjects and their a responsiveness to checkpoint inhibition treatment and the machine-learning classifier is trained to predict responsiveness to the treatment, and generating a checkpoint inhibition responsiveness classification predictive of the subject's responding to the checkpoint inhibition with the trained machine-learning classifier, and reporting the checkpoint inhibition responsiveness classification using a graphical user interface. Also provided are a computer system for performing the method and a machine learning classifier trained by the method.
    Type: Application
    Filed: December 3, 2018
    Publication date: June 4, 2020
    Applicant: ILLUMINA, INC.
    Inventors: Shile Zhang, Mengchi Wang, Aaron Wise, Han Kang, Vitor Ferreira Onuchic, Kristina Kruglyak
  • Patent number: D896241
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: September 15, 2020
    Assignee: Illumina, Inc.
    Inventors: Shile Zhang, Kristina Kruglyak, Mengchi Wang
  • Patent number: D956780
    Type: Grant
    Filed: August 12, 2020
    Date of Patent: July 5, 2022
    Assignee: Illumina, Inc.
    Inventors: Shile Zhang, Kristina Kruglyak, Mengchi Wang
  • Patent number: D956781
    Type: Grant
    Filed: August 12, 2020
    Date of Patent: July 5, 2022
    Assignee: Illumina, Inc.
    Inventors: Shile Zhang, Kristina Kruglyak, Mengchi Wang
  • Patent number: D956782
    Type: Grant
    Filed: August 12, 2020
    Date of Patent: July 5, 2022
    Assignee: Illumina, Inc.
    Inventors: Shile Zhang, Kristina Kruglyak, Mengchi Wang